In line with my expectations, note the emphasis on the wording “as far out as 2038” without reading tea leaves this implies that of the 61 patents many will start expiring from 2028 (as I have pointed out) so the monopoly runway ain’t as long as some (fanboys) may think it is. It is one thing to have faith but one does not go in blindly. Pnv should do fine but it won’t be as good as many had hoped. Need new products to come on line.
- Forums
- ASX - By Stock
- Ann: PolyNovo presents at Evans & Partners Healthcare Conference
In line with my expectations, note the emphasis on the wording...
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.04 |
Change
-0.030(1.45%) |
Mkt cap ! $1.409B |
Open | High | Low | Value | Volume |
$2.09 | $2.11 | $2.03 | $1.727M | 838.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 299194 | $2.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.04 | 1559 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 294258 | 2.020 |
3 | 6246 | 2.010 |
7 | 31240 | 2.000 |
1 | 1500 | 1.995 |
2 | 2005 | 1.990 |
Price($) | Vol. | No. |
---|---|---|
2.050 | 500 | 1 |
2.070 | 25500 | 2 |
2.100 | 10972 | 2 |
2.110 | 13714 | 2 |
2.120 | 43987 | 4 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online